Fonar Current Ratio 2010-2025 | FONR
Fonar current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Fonar Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.14B | $0.01B | 10.05 |
| 2024-12-31 | $0.14B | $0.01B | 11.24 |
| 2024-09-30 | $0.14B | $0.01B | 9.64 |
| 2024-06-30 | $0.14B | $0.02B | 7.86 |
| 2024-03-31 | $0.14B | $0.02B | 9.37 |
| 2023-12-31 | $0.13B | $0.01B | 9.35 |
| 2023-09-30 | $0.13B | $0.01B | 9.07 |
| 2023-06-30 | $0.13B | $0.02B | 8.04 |
| 2023-03-31 | $0.12B | $0.01B | 8.76 |
| 2022-12-31 | $0.12B | $0.01B | 8.79 |
| 2022-09-30 | $0.12B | $0.02B | 8.01 |
| 2022-06-30 | $0.12B | $0.02B | 7.09 |
| 2022-03-31 | $0.11B | $0.01B | 8.07 |
| 2021-12-31 | $0.11B | $0.01B | 8.13 |
| 2021-09-30 | $0.11B | $0.02B | 6.73 |
| 2021-06-30 | $0.11B | $0.02B | 5.42 |
| 2021-03-31 | $0.10B | $0.02B | 6.06 |
| 2020-12-31 | $0.10B | $0.02B | 6.00 |
| 2020-09-30 | $0.10B | $0.02B | 5.32 |
| 2020-06-30 | $0.10B | $0.02B | 5.14 |
| 2020-03-31 | $0.09B | $0.02B | 6.14 |
| 2019-12-31 | $0.09B | $0.02B | 6.03 |
| 2019-09-30 | $0.09B | $0.01B | 6.25 |
| 2019-06-30 | $0.09B | $0.01B | 6.04 |
| 2019-03-31 | $0.08B | $0.01B | 6.99 |
| 2018-12-31 | $0.07B | $0.01B | 6.33 |
| 2018-09-30 | $0.07B | $0.01B | 5.99 |
| 2018-06-30 | $0.07B | $0.02B | 4.60 |
| 2018-03-31 | $0.06B | $0.01B | 4.96 |
| 2017-12-31 | $0.06B | $0.01B | 4.43 |
| 2017-09-30 | $0.06B | $0.01B | 4.05 |
| 2017-06-30 | $0.05B | $0.01B | 3.75 |
| 2017-03-31 | $0.05B | $0.01B | 3.52 |
| 2016-12-31 | $0.05B | $0.02B | 2.81 |
| 2016-09-30 | $0.05B | $0.02B | 2.57 |
| 2016-06-30 | $0.05B | $0.02B | 2.21 |
| 2016-03-31 | $0.05B | $0.02B | 2.74 |
| 2015-12-31 | $0.05B | $0.02B | 2.57 |
| 2015-09-30 | $0.05B | $0.02B | 2.38 |
| 2015-06-30 | $0.04B | $0.02B | 2.32 |
| 2015-03-31 | $0.04B | $0.02B | 2.13 |
| 2014-12-31 | $0.05B | $0.02B | 2.24 |
| 2014-09-30 | $0.05B | $0.02B | 2.07 |
| 2014-06-30 | $0.04B | $0.02B | 2.05 |
| 2014-03-31 | $0.04B | $0.02B | 1.95 |
| 2013-12-31 | $0.04B | $0.02B | 1.88 |
| 2013-09-30 | $0.04B | $0.02B | 1.84 |
| 2013-06-30 | $0.04B | $0.02B | 1.79 |
| 2013-03-31 | $0.04B | $0.02B | 1.63 |
| 2012-12-31 | $0.03B | $0.02B | 1.38 |
| 2012-09-30 | $0.03B | $0.02B | 1.30 |
| 2012-06-30 | $0.03B | $0.02B | 1.23 |
| 2012-03-31 | $0.03B | $0.02B | 1.20 |
| 2011-12-31 | $0.03B | $0.02B | 1.15 |
| 2011-09-30 | $0.02B | $0.02B | 1.06 |
| 2011-06-30 | $0.02B | $0.02B | 0.98 |
| 2011-03-31 | $0.02B | $0.02B | 0.70 |
| 2010-12-31 | $0.02B | $0.03B | 0.61 |
| 2010-09-30 | $0.02B | $0.03B | 0.61 |
| 2010-06-30 | $0.02B | $0.03B | 0.59 |
| 2010-03-31 | $0.02B | $0.03B | 0.59 |
| 2009-12-31 | $0.02B | $0.03B | 0.59 |
| 2009-09-30 | $0.02B | $0.03B | 0.64 |
| 2009-06-30 | $0.02B | $0.03B | 0.63 |
| 2009-03-31 | $0.02B | $0.03B | 0.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.096B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $152.324B | 38.13 |
| Stryker (SYK) | United States | $149.641B | 31.29 |
| EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
| Medtronic (MDT) | Ireland | $114.146B | 16.18 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.534B | 28.19 |
| GE HealthCare Technologies (GEHC) | United States | $34.575B | 16.42 |
| Agilent Technologies (A) | United States | $34.457B | 22.46 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
| Insulet (PODD) | United States | $20.934B | 82.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
| Baxter (BAX) | United States | $15.298B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.887B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
| Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
| Haemonetics (HAE) | United States | $3.724B | 16.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.454B | 28.70 |
| ICU Medical (ICUI) | United States | $3.341B | 24.63 |
| QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| AtriCure (ATRC) | United States | $1.580B | 0.00 |
| Acuren (TIC) | United States | $1.397B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
| Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
| AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
| Neogen (NEOG) | United States | $1.194B | 15.28 |
| BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
| InMode (INMD) | Israel | $0.963B | 9.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.53 |
| Evolus (EOLS) | United States | $0.623B | 0.00 |
| CeriBell (CBLL) | United States | $0.596B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
| Valneva SE (VALN) | France | $0.502B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.295B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.264B | 12.01 |
| Brainsway (BWAY) | Israel | $0.246B | 65.00 |
| Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
| TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.29 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.82 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |